1

Customized phage therapies to eradicate
harmful bacteria in chronic diseases

We develop both natural and engineered phage therapies that target harmful bacteria in microbiome-related chronic diseases such as IBD and cancer

Our phage therapy development and target discovery technologies were developed by world-leading scientists from top-tier institutions including MIT and the Weizmann Institute of Science

LEARN ABOUT OUR TECHNOLOGY

BiomX’s founders, management and investors all have a long history of excellence that is propelling us to continued success and innovation.

LEARN ABOUT OUR LEADERSHIP

OUR INVESTORS